Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis;Selektion zur Peritonektomie mit Hyperthermer Intraoperativer Chemotherapie (HIPEC) bei Peritonealkarzinose

Zentralblatt fur Chirurgie

Volumn 133, Issue 5, 2008, Pages 468-472

  Konigsrainer I ^a   Aschoff, P ^a   Zieker, D ^a   Beckert, S ^a   Glatzle, J ^a   Pfannenberg, C ^a   Miller, S ^a   Hartmann, J T ^a   Schroeder, T H ^a   Brucher B L D M ^a   Konigsrainer A ^a  

^a Die Institutsangaben Sind am Ende des Beitrags Gelistet ^*  (Germany)

Author keywords

Peritoneal carcinomatosis; PET CT scan; Preoperative evaluation; Selection criteria

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TUMOR; HUMAN; HYPERTHERMIC THERAPY; LAPAROSCOPY; METASTASIS; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PERITONEUM; PERITONEUM TUMOR; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REGIONAL PERFUSION;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LAPAROSCOPY; PATIENT SELECTION; PERITONEAL NEOPLASMS; PERITONEUM; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53849084141     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076973     Document Type: Article

References (37)

1. Antoch G, Saoudi N, Kuehl H et al. Accuracy of whole-body dualmodality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004; 22: 4357-4368
2. Armstrong DK, Bundy B, Wenzel L et al. Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 34-43
3. Berger KL, Nicholson SA, Dehdashti F et al. FDG-PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000; 174: 1005 -1008
4. Coakley FV, Choi PH, Gougoutas CA et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002; 223: 495-499
5. De Bree E, Koops W, Kröger R et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 2004; 86: 64-73
6. Dromain C, Leboulleux S, Auperin A et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 2007; 33: 87-93
7. Esquivel J, Sticca R, Sugarbaker P et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 2007; 14: 128-133
8. Esquivel J, Vidal-Jove J, Steves MA et al. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993; 113: 631-636
9. Feldman AL Libutti SK, Pingpank JF et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003; 21: 4560-4567
10. Glehen O, Mithieux F, Osinsky D et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 2003; 21: 799-806
11. Glehen O, Osinsky D, Cotte E et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003; 10: 863-869
12. Harmon RL Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2005; 8: 2-3
13. Havrilesky LJ, Kulasingam SL, Matchar DB et al. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 2005; 97: 183-191
14. Huebner RH, Park KC, Shepherd JE et al. A meta-analysis of the literature for whole-body FDG-PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-1189
15. Jacquet P, Jelinek JS, Steves MA et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993; 72: 1631-1636
16. Jacquet P, Jelinek JS, Chang D et al. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 1995; 181: 530-538
17. Jacquet P. Stephens AD, Averbach AM et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77: 2622-2629
18. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996; 82: 359-374
19. Kianmanesh R, Scaringi S, Sabate JM et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007; 245: 597-603
20. Look M, Chang D, Sugarbaker PH. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 2003; 13: 764-70
21. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003; 12: 585-603
22. Moran BJ, Mukherjee A, Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg 2006; 93: 100-104
23. Stahl A, Ott K, Weber WA et al. FDG-PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003; 30: 288-295
24. Stephens AD, Alderman R, Chang D et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6: 790-796
25. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-132
26. Sugarbaker PH, Welch LS, Mohamed F et al. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 2003; 12: 605-621
27. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43: 15-25
28. Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003; 21: 233-248
29. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbecks Arch Surg 1999; 384: 576-587
30. 18F-FDG-PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging 2004; 31: 1413-1420
31. Tanaka T. Kawai Y, Kanal M et al. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg 2002; 184: 433-436
32. 18)F-FDG-PET. J Nucl Med 2003; 44: 1407-1412
33. Valle M, Garofalo A. Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol 2006; 32: 625-627
34. Verwaal VJ, van Tinteren H, Ruth SV et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85: 61-67
35. Verwaal VJ, van Ruth S, de Bree E et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743
36. Whiteford MH, Whiteford HM, Yee LF et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43: 759-767
37. Yan TD, Haveric N, Carmignani CP et al. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 2005; 103: 839-849